Exploring the intricate links between the environment and respiratory function, environmental & occupational lung health addresses the impact of air pollution, chemical exposures, and workplace hazards on pulmonary disease incidence. Chronic exposure to particulate matter, volatile organic compounds, and occupational allergens is strongly associated with diseases like COPD, hypersensitivity pneumonitis, and pneumoconiosis. Increasing attention is being given to identifying and mitigating newer risk factors such as nanomaterial inhalation, indoor biomass smoke, and emissions from industrial solvents. Technological advancements are enabling more precise exposure assessment and real-time monitoring, helping clinicians and researchers better understand dose-response relationships. There is also a growing emphasis on multidisciplinary approaches that integrate occupational medicine, environmental science, and public health to shape effective interventions. Efforts to reduce disparities in exposure and improve workplace standards are gaining momentum as part of a broader push toward sustainable respiratory health practices.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation